Why the study?
Does pretreatment with heparin or N-acetylheparin reduce myocardial infarct size in a canine model of ischemia and reperfusion?
Does pretreatment with heparin or N-acetylheparin reduce myocardial infarct size in a canine model of ischemia and reperfusion?
Pretreatment with heparin or N-acetylheparin significantly reduces myocardial infarct size in a canine model of ischemia-reperfusion injury, independent of anticoagulant effects.
No takes yet. Share an insight, caveat, or question.
Does not alter clinical practice; leaves open translation of heparin-mediated cardioprotection from canine ischemia-reperfusion to humans.
Gralinski et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: